Reteplase Fc-fusions produced in N. benthamiana are able to dissolve blood clots ex vivo.
Thrombolytic and fibrinolytic therapies are effective treatments to dissolve blood clots in stroke therapy. Thrombolytic drugs activate plasminogen to its cleaved form plasmin, a proteolytic enzyme that breaks the crosslinks between fibrin molecules. The FDA-approved human tissue plasminogen activat...
Saved in:
| Main Authors: | Shiva Izadi, Mokhtar Jalali Javaran, Sajad Rashidi Monfared, Alexandra Castilho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0260796&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Asn12 and Asn278: Critical Residues for In Vitro Biological Activity of Reteplase
by: Naganath Mandi, et al.
Published: (2010-01-01) -
Fabrication and Ex-vivo Evaluation of Olanzapine Nanoparticles Based Dissolved Microneedle for Transdermal Delivery
by: Abulfadhel jaber neamah AL-shaibani, et al.
Published: (2025-06-01) -
Plant-related quality attributes affecting FcγRIIIa binding: affinity chromatography analysis of rituximab glycovariants from Nicotiana benthamiana
by: Sara Tengattini, et al.
Published: (2025-06-01) -
Tenecteplase vs Reteplase in Patients with Acute ST-Elevation Myocardial Infarction: A Retrospective Cohort Study
by: Adham Mohamed PharmD, et al.
Published: (2025-02-01) -
DIFFERENT RESPONSE OF HUMAN BLOOD NEUTROPHIL FCᵧRIIIB (CD16) TO EX VIVO MODELING OF BACTEREMIA BY PATHOGENIC AND OPPORTUNISTIC MICROORGANISMS
by: Alexander Leonidovich Kravtsov, et al.
Published: (2019-08-01)